Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Arterial Occlusive Events in Chronic Myeloid Leukemia Patients Treated with Ponatinib in the Real-Life Practice: Prophylaxis and Identification of Risk Factors

Blood (2018) 132 (Supplement 1): 3006.

https://doi.org/10.1182/blood-2018-99-111502

Published: 2018

Journal Articles

A Cross-Sectional Analysis of Cardiovascular Disease in the Hemophilia Population

Blood (2015) 126 (23): 761.

https://doi.org/10.1182/blood.V126.23.761.761

Published: 2015

Journal Articles

A Randomized Phase III Trial of Melphalan and Dexamethasone (MDex) Versus Bortezomib, Melphalan and Dexamethasone (BMDex) for Untreated Patients with AL Amyloidosis

Blood (2014) 124 (21): 35.

https://doi.org/10.1182/blood.V124.21.35.35

Published: 2014

Journal Articles

Evaluation of Monitoring Indicators of Antiplatelet Therapy

Liping Ma, MD

Blood (2014) 124 (21): 4996.

https://doi.org/10.1182/blood.V124.21.4996.4996

Published: 2014

Journal Articles

Revascularization Strategies and In-Hospital Outcomes In Acute Coronary Syndromes (ACS) Complicated By Von Willebrand Disease (VWD)

Patrick F. Fogarty, M.D., William H. Matthai, Jr., M.D., Anne Boccuti, B.A., Rolando Vega, B.A., Elaine Y Chiang, M.D., Phyllis A. Gimotty, Ph.D.

Blood (2013) 122 (21): 2354.

https://doi.org/10.1182/blood.V122.21.2354.2354

Published: 2013

Journal Articles

Deficient ADAMTS13 Activity in Ticlopidine-Associated Thrombotic Thrombocytopenic Purpura (TTP) in Populations From Japan in 2012: Validation of Findings Initially Reported in the United States in 1998 and 2000.

Charles Bennett, MD, PhD, MPP, Masanori Matsumoto, MD, Peter Georgantopoulos, MPH, AM, Sony Jacob, MD, Brianne L Dunn, PharmD, Zaina Parvez Qureshi, PhD, MPH, Nicholas Bandarenko, III, MD, Hau C. Kwaan, MD, PhD, Jeffrey Winters, MD, Ravindra Sarode, MD, Joseph E Kiss, MD, Constance Danielson, MD, PhD, Thomas L. Ortel, MD, PhD, Thomas Raife, MD, William F Clark, MD, Gail Rock, PhD, MD, FRCP, X. Long Zheng, MD, PhD, Dennis Raisch, Ph.D., M.S., R.Ph., Yoshihiro Fujimura, MD, PhD

Blood (2012) 120 (21): 2203.

https://doi.org/10.1182/blood.V120.21.2203.2203

Published: 2012

Journal Articles

Translating Research Into Policy: A Review of Pharmacovigilance Efforts From the Southern Network On Adverse Reactions (SONAR) Group

Charles Bennett, MD, PhD, MPP, Leann Norris, PharmD, Zaina Parvez Qureshi, PhD, MPH, April Miller, PharmD, Brandon Bookstaver, PharmD, BCPS (AQ-ID), AAHIVE, Donald Mattison, M.D., CAPT, USPHS

Blood (2011) 118 (21): 4756.

https://doi.org/10.1182/blood.V118.21.4756.4756

Published: 2011

Journal Articles

Percutaneous Coronary Intervention (PCI) in Combined FV and FVIII Deficiency with a Novel LMAN1 Mutation.

Anjan Patel, MD, Vera Malkovska, MD, Rachel Salit, MD, Robert Lager, MD, Huihui Lui, PhD, Bin Zhang, PhD

Blood (2009) 114 (22): 4448.

https://doi.org/10.1182/blood.V114.22.4448.4448

Published: 2009

Journal Articles

Severe Thrombocytopenia (<50×10 9 Cells/l) Associated with Glycoprotein IIb/IIIa Inhibitors in Patients with Cardio Vascular Illness: A Cohort Study On Clinical Course and Outcomes.

Girish N Viswanathan, MD, MRCP, Gnanamoorthy Mayurathan, MD, John Hardy, Sheila Jamieson, Patrick Kestevan, PhD, FRCPath, Azfar Zaman, BSc, MD, FRCP

Blood (2009) 114 (22): 4452.

https://doi.org/10.1182/blood.V114.22.4452.4452

Published: 2009

Journal Articles

Are There Two Distinct Mechanistic Pathways That Explain the Varying Clinical Presentations, Laboratory Findings, and Outcomes of Thienopyridine-Associated Thrombotic Thrombocytopenic Purpura (TTP)?.

Benjamin Kim, MD, Kenneth R. Carson, MD, Kathryn McCaffrey, BA, Denise Finley, Anaadriana Zakarija, MD, Nicholas Bandarenko, MD, Dilip K. Pandey, MBBS, MS, PhD, Dennis W. Raisch, PhD, Hau C. Kwaan, MD, PhD, Paul R. Yarnold, PhD, Charles L. Bennett, MD, PhD, MPP

Blood (2004) 104 (11): 860.

https://doi.org/10.1182/blood.V104.11.860.860

Published: 2004

Journal Articles

Clopidogrel Resistance and Aspirin Resistance - a Cause of Coronary Artery Stent Thrombosis?.

Robert Klamroth, MD, Stefan Hoffmann, MD, Dietrich Andresen, MD, Helmut Landgraf, MD

Blood (2004) 104 (11): 4070.

https://doi.org/10.1182/blood.V104.11.4070.4070

Published: 2004

Journal Articles

Subacute Thrombotic Events Associated with Drug Eluting Cardiac Stents May Be Localized Hypersensitivity Reactions to Polymers.

Charles Bennett, MD, PhD, Jonathan Nebeker, MD, Renu Virmani, MD, June McKoy, MD, JD, MPH, Jenny Hoffman, MD, Dennis Raisch, PhD, Dennis West, MD, Matthew Samore, MD, Paul Yarnold, PhD, Charles Davidson, MD, Steven Belknap, MD, Marc Feldman, MD6

Blood (2004) 104 (11): 2198.

https://doi.org/10.1182/blood.V104.11.2198.2198

Published: 2004

Journal Articles

Glycoprotein Ia gene C807T polymorphism and risk for major adverse cardiac events within the first 30 days after coronary artery stenting

Nicolas von Beckerath, Werner Koch, Julinda Mehilli, Corinna Böttiger, Albert Schömig, Adnan Kastrati

Blood (2000) 95 (11): 3297–3301.

https://doi.org/10.1182/blood.V95.11.3297

Published: 2000

NARROW

Arterial Occlusive Events in Chronic Myeloid Leukemia Patients Treated with Ponatinib in the Real-Life Practice: Prophylaxis and Identification of Risk Factors

A Cross-Sectional Analysis of Cardiovascular Disease in the Hemophilia Population

A Randomized Phase III Trial of Melphalan and Dexamethasone (MDex) Versus Bortezomib, Melphalan and Dexamethasone (BMDex) for Untreated Patients with AL Amyloidosis

Evaluation of Monitoring Indicators of Antiplatelet Therapy

Revascularization Strategies and In-Hospital Outcomes In Acute Coronary Syndromes (ACS) Complicated By Von Willebrand Disease (VWD)

Deficient ADAMTS13 Activity in Ticlopidine-Associated Thrombotic Thrombocytopenic Purpura (TTP) in Populations From Japan in 2012: Validation of Findings Initially Reported in the United States in 1998 and 2000.

Translating Research Into Policy: A Review of Pharmacovigilance Efforts From the Southern Network On Adverse Reactions (SONAR) Group

Percutaneous Coronary Intervention (PCI) in Combined FV and FVIII Deficiency with a Novel LMAN1 Mutation.

Severe Thrombocytopenia (<50×10 9 Cells/l) Associated with Glycoprotein IIb/IIIa Inhibitors in Patients with Cardio Vascular Illness: A Cohort Study On Clinical Course and Outcomes.

Are There Two Distinct Mechanistic Pathways That Explain the Varying Clinical Presentations, Laboratory Findings, and Outcomes of Thienopyridine-Associated Thrombotic Thrombocytopenic Purpura (TTP)?.

Clopidogrel Resistance and Aspirin Resistance - a Cause of Coronary Artery Stent Thrombosis?.

Subacute Thrombotic Events Associated with Drug Eluting Cardiac Stents May Be Localized Hypersensitivity Reactions to Polymers.

Glycoprotein Ia gene C807T polymorphism and risk for major adverse cardiac events within the first 30 days after coronary artery stenting

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only